Baldur Sveinbjørnsson Selected Research

Neuroblastoma

11/2017	Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.
1/2016	The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
7/2011	MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
8/2006	The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.
12/2004	Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baldur Sveinbjørnsson Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 09/2002
6	Melanoma (Melanoma, Malignant) 01/2024 - 09/2002
5	Carcinoma (Carcinomatosis) 01/2021 - 09/2002
5	Necrosis 01/2021 - 12/2004
5	Neuroblastoma 11/2017 - 12/2004
4	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2015
3	Carcinogenesis 03/2022 - 01/2016
3	Inflammation (Inflammations) 01/2016 - 12/2011
2	Merkel Cell Carcinoma 03/2022 - 06/2018
2	Triple Negative Breast Neoplasms 01/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 10/2019 - 01/2017
2	Fibrosarcoma 01/2017 - 09/2002
2	Anastomotic Leak 11/2016 - 12/2011
2	Experimental Melanoma 01/2016 - 06/2014
2	Vascular Calcification 03/2007 - 05/2006
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Disease Progression 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2019
1	Extranodal Extension 09/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2016
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Skin Neoplasms (Skin Cancer) 06/2014
1	Pain (Aches) 12/2011
1	Lymphoma (Lymphomas) 08/2010
1	Osteoporosis 07/2007

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 01/2021 - 09/2002
9	LTX-315IBA 01/2024 - 06/2014
6	Proteins (Proteins, Gene)FDA Link 02/2020 - 09/2002
3	CytokinesIBA 03/2022 - 03/2013
3	LTX-401IBA 09/2019 - 01/2016
3	MicroRNAs (MicroRNA)IBA 06/2018 - 07/2011
3	OsteoprotegerinIBA 03/2007 - 11/2005
2	AlarminsIBA 01/2024 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2004
2	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2017
2	AntigensIBA 01/2024 - 10/2018
2	Tumor Viral Antigens (Large T Antigen)IBA 03/2022 - 04/2015
2	CarcinogensIBA 01/2021 - 04/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 03/2013
2	Interferon-gamma (Interferon, gamma)IBA 09/2019 - 12/2004
2	CalciumIBA 11/2017 - 01/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2016 - 12/2011
2	lactoferricin BIBA 08/2006 - 09/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024
1	Nucleic AcidsIBA 01/2024
1	Hormones (Hormone)IBA 01/2021
1	LuciferasesIBA 01/2021
1	Viral ProteinsIBA 02/2020
1	Oncogene Proteins (Oncogene Protein)IBA 02/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	PeptidomimeticsIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 06/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018
1	redaporfinIBA 01/2018
1	ChemokinesIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Antimicrobial Cationic PeptidesIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2016
1	SteroidsIBA 11/2016
1	TetraspaninsIBA 10/2016
1	IntegrinsIBA 10/2016
1	Amino Acids FDA Link 01/2016
1	F-chemotactic peptideIBA 01/2016
1	Phospho-Specific AntibodiesIBA 01/2016
1	AcidsIBA 01/2016
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2016
1	isothiocyanic acidIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2016
1	cyclosporin HIBA 01/2016
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2016
1	Complementary DNA (cDNA)IBA 01/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2015
1	Protein Kinases (Protein Kinase)IBA 03/2013
1	Mitogen-Activated Protein KinasesIBA 03/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013
1	InterferonsIBA 03/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011
1	Opioid Analgesics (Opioids)IBA 12/2011
1	AntagomirsIBA 07/2011
1	Culture MediaIBA 07/2011
1	Heparin (Liquaemin)FDA LinkGeneric 07/2007
1	Antimicrobial PeptidesIBA 08/2006
1	Caspase 6IBA 08/2006

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2004
4	Injections 01/2021 - 08/2006
3	Immunotherapy 01/2019 - 01/2017
2	Aftercare (After-Treatment) 01/2021 - 06/2014
1	Radiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2018
1	Blood Transfusion (Blood Transfusions) 11/2016
1	Heterologous Transplantation (Xenotransplantation) 01/2016